Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study

Ibrutinib and other targeted inhibitors of B-cell receptor signaling achieve impressive clinical results for patients with chronic lymphocytic leukemia (CLL). A treatment-induced rise in absolute lymphocyte count (ALC) has emerged as a class effect of kinase inhibitors in CLL and warrants further in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Herman, Sarah E. M., Niemann, Carsten U., Farooqui, Mohammed, Jones, Jade, Mustafa, Rashida Z., Lipsky, Andrew, Saba, Nakhle, Martyr, Sabrina, Soto, Susan, Valdez, Janet, Gyamfi, Jennifer A., Maric, Irina, Calvo, Katherine R., Pedersen, Lone B., Geisler, Christian H., Liu, Delong, Marti, Gerald E., Aue, Georg, Wiestner, Adrian
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185271/
https://ncbi.nlm.nih.gov/pubmed/24699307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2014.122
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados